Malignant Neoplasm of Lung - Multiple Primary Sites

Malignant Neoplasm of Lung - Multiple Primary Sites — Trials · CancerIndex

Clinical trials

Registered studies

9 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04982900	Treatment of EGFR-TKI for Residual Lesions of Multiple Synchronous Ground-glass Opacities(TERMGGO)	unknown	Phase 2	138	Ruijin HospitalOTHER	1	Oct 5, 2021	clinicaltrials
NCT04840758	Stereotactic Ablation Radiotherapy Combined With Sintilimab in Early Inoperable Synchronous Multiple Primary Lung Cancer	unknown	Phase 1 / Phase 2	39	The First Affiliated Hospital of Xiamen UniversityOTHER	0	Apr 12, 2021